Ulf Bremberg joined Beactica as Chief Scientific Officer in 2015. Ulf has a background in medicinal chemistry and significant experience of industrial pharmaceutical research, with emphasis on early discovery, patent strategies and oncology. He previously headed up the Lead Identification Facility at the Drug Discovery & Development Platform of SciLifeLab, a national pharmaceutical research infrastructure formed by a collaboration between Karolinska Institute, KTH Royal Institute of Technology, Stockholm University and Uppsala University. Earlier positions include Chief Scientific Officer of OncoTargeting AB as well as positions as Chemistry Team Leader and Medicinal Chemist at Biovitrum and Pharmacia. Ulf did his post-doc at the Scripps Research Institute and holds a Ph.D. in Organic Chemistry from KTH Royal Institute of Technology.
Sign up for the Beactica newsletter to recieve our latest news and updates